Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 154

1.

ANNALS EXPRESS: The effect of storage conditions on sample stability in the routine clinical laboratory.

Kift RL, Byrne C, Liversidge R, Babbington F, Knox C, Binns J, Barth JH.

Ann Clin Biochem. 2015 Mar 16. pii: 0004563215580000. [Epub ahead of print]

PMID:
25780248
2.

A Perspective on Metabolic Syndrome and Nonalcoholic Fatty Liver Disease.

Targher G, Byrne CD.

Metab Syndr Relat Disord. 2015 Feb 25. [Epub ahead of print]

PMID:
25714786
3.

An increased high-density lipoprotein cholesterol/apolipoprotein A-I ratio is associated with increased cardiovascular and all-cause mortality.

Sung KC, Ryu S, Wild SH, Byrne CD.

Heart. 2015 Apr 1;101(7):553-8. doi: 10.1136/heartjnl-2014-306784. Epub 2015 Jan 30.

PMID:
25637367
4.

Intraductal tubulopapillary neoplasm of pancreas with associated invasive carcinoma, lymph node, rectal and hepatic metastases.

Matthews Y, McKenzie C, Byrne C, Kench JG.

Pathology. 2015 Feb;47(2):169-71. doi: 10.1097/PAT.0000000000000228. No abstract available.

PMID:
25551309
5.

Composition of dietary macronutrient intake is not associated with prevalence of coronary artery calcification in healthy korean adults.

Sung KC, Sung E, Byrne CD, Kim YB, Ahn CW, Chung HK.

Ann Nutr Metab. 2015;66(1):36-43. doi: 10.1159/000369563. Epub 2014 Dec 13.

PMID:
25531976
6.

New approaches to cardiovascular surgery.

Neely RC, Leacche M, Byrne CR, Norman AV, Byrne JG.

Curr Probl Cardiol. 2014 Dec;39(12):427-66. doi: 10.1016/j.cpcardiol.2014.07.006. Epub 2014 Jul 30.

PMID:
25498978
7.

Perceptions of Weight, Diabetes and Willingness to Participate in Randomised Controlled Trials of Bariatric Surgery for Patients With Type 2 Diabetes Mellitus and Body Mass Index 30-39.9 kg/m2.

Summers RH, Moore M, Byrne J, Byrne C, Mullee M, Welbourn R, Elsey H, Roderick P.

Obes Surg. 2014 Nov 22. [Epub ahead of print]

PMID:
25416084
8.

The reduced cost of providing a nationally recognised service for familial hypercholesterolaemia.

Pears R, Griffin M, Watson M, Wheeler R, Hilder D, Meeson B, Bacon S, Byrne CD.

Open Heart. 2014 Aug 12;1(1):e000015. doi: 10.1136/openhrt-2013-000015. eCollection 2014.

9.

Application of new guidelines for the primary prevention of atherosclerotic cardiovascular disease in a korean population.

Kim NH, So MS, Kang JG, Cho DS, Byrne CD, Lee SJ, Sung KC.

J Atheroscler Thromb. 2015 Mar 23;22(3):293-303. doi: 10.5551/jat.26682. Epub 2014 Oct 4.

10.

Evaluation of bioelectrical impedance analysis for identifying overweight individuals at increased cardiometabolic risk: a cross-sectional study.

Lamb MJ, Byrne CD, Wilson JF, Wild SH.

PLoS One. 2014 Sep 22;9(9):e106134. doi: 10.1371/journal.pone.0106134. eCollection 2014.

11.

CKD and nonalcoholic fatty liver disease.

Targher G, Chonchol MB, Byrne CD.

Am J Kidney Dis. 2014 Oct;64(4):638-52. doi: 10.1053/j.ajkd.2014.05.019. Epub 2014 Jul 30. Review.

PMID:
25085644
12.

Effects of purified eicosapentaenoic and docosahexaenoic acids in nonalcoholic fatty liver disease: results from the Welcome* study.

Scorletti E, Bhatia L, McCormick KG, Clough GF, Nash K, Hodson L, Moyses HE, Calder PC, Byrne CD; WELCOME Study.

Hepatology. 2014 Oct;60(4):1211-21.

PMID:
25043514
13.

Daily energy expenditure, cardiorespiratory fitness and glycaemic control in people with type 1 diabetes.

Valletta JJ, Chipperfield AJ, Clough GF, Byrne CD.

PLoS One. 2014 May 14;9(5):e97534. doi: 10.1371/journal.pone.0097534. eCollection 2014.

14.

Ectopic fat, insulin resistance, and nonalcoholic fatty liver disease: implications for cardiovascular disease.

Byrne CD, Targher G.

Arterioscler Thromb Vasc Biol. 2014 Jun;34(6):1155-61. doi: 10.1161/ATVBAHA.114.303034. Epub 2014 Apr 17. Review.

PMID:
24743428
15.

Nonalcoholic fatty liver disease is independently associated with an increased incidence of chronic kidney disease in patients with type 1 diabetes.

Targher G, Mantovani A, Pichiri I, Mingolla L, Cavalieri V, Mantovani W, Pancheri S, Trombetta M, Zoppini G, Chonchol M, Byrne CD, Bonora E.

Diabetes Care. 2014 Jun;37(6):1729-36. doi: 10.2337/dc13-2704. Epub 2014 Apr 2.

PMID:
24696459
16.

Global gene repression by the steroid receptor coactivator SRC-1 promotes oncogenesis.

Walsh CA, Bolger JC, Byrne C, Cocchiglia S, Hao Y, Fagan A, Qin L, Cahalin A, McCartan D, McIlroy M, O'Gaora P, Xu J, Hill AD, Young LS.

Cancer Res. 2014 May 1;74(9):2533-44. doi: 10.1158/0008-5472.CAN-13-2133. Epub 2014 Mar 19.

PMID:
24648347
17.

Towards a personalised diagnosis of type 2 diabetes.

Wild SH, Byrne CD.

Lancet Diabetes Endocrinol. 2013 Sep;1(1):6-7. doi: 10.1016/S2213-8587(13)70010-X. Epub 2013 Feb 21. No abstract available.

PMID:
24622254
18.

Lower 25-hydroxyvitamin D3 levels and increased risk of liver diseases: is there a causal link?

Targher G, Byrne CD.

Endocrine. 2014 Sep;47(1):3-4. doi: 10.1007/s12020-014-0220-3. Epub 2014 Mar 5. No abstract available.

PMID:
24595898
19.

Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes.

Targher G, Valbusa F, Bonapace S, Bertolini L, Zenari L, Pichiri I, Mantovani A, Zoppini G, Bonora E, Barbieri E, Byrne CD.

Nutr Metab Cardiovasc Dis. 2014 Jun;24(6):663-9. doi: 10.1016/j.numecd.2014.01.005. Epub 2014 Jan 21.

PMID:
24594085
20.

Risk of cardiovascular, cardiac and arrhythmic complications in patients with non-alcoholic fatty liver disease.

Ballestri S, Lonardo A, Bonapace S, Byrne CD, Loria P, Targher G.

World J Gastroenterol. 2014 Feb 21;20(7):1724-45. doi: 10.3748/wjg.v20.i7.1724. Review.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk